Supriya Lifescience Ltd vs Trident Lifeline Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 04, 2026

Key Highlights

The Latest Trading Price of Supriya Lifescience Ltd is ₹ 694.95 as of 04 May 09:07 . The P/E Ratio of Supriya Lifescience Ltd changed from 0 on March 2022 to 0 on March 2025 . This represents a CAGR of 0.0% over 4 yearsThe P/E Ratio of Trident Lifeline Ltd changed from 30.4 on March 2023 to 25.1 on March 2025 . This represents a CAGR of -6.19% over 3 years The Market Cap of Supriya Lifescience Ltd changed from ₹ 0 crore on March 2022 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 4 yearsThe Market Cap of Trident Lifeline Ltd changed from ₹ 182.95 crore on March 2023 to ₹ 295.53 crore on March 2025 . This represents a CAGR of 17.33% over 3 years The revenue of Supriya Lifescience Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Trident Lifeline Ltd for the Dec '25 is ₹ 30.34 crore as compare to the Sep '25 revenue of ₹ 33.01 crore. This represent the decline of -8.09% The ebitda of Supriya Lifescience Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Trident Lifeline Ltd for the Dec '25 is ₹ 9.72 crore as compare to the Sep '25 ebitda of ₹ 8.53 crore. This represent the growth of 13.95% The net profit of Supriya Lifescience Ltd changed from ₹ 0 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of 0.0% The net profit of Trident Lifeline Ltd changed from ₹ 1.6 crore to ₹ 4.65 crore over 7 quarters. This represents a CAGR of 83.98% The Dividend Payout of Supriya Lifescience Ltd changed from 3.2 % on March 2021 to 4.28 % on March 2025 . This represents a CAGR of 5.99% over 5 yearsThe Dividend Payout of Trident Lifeline Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Supriya Lifescience Ltd

Supriya Lifescience Limited was initially constituted on October 29, 1985, as a 'Partnership Firm under the name M/s Supriya Chemicals'.
The Partnership Firm was last re-constituted pursuant to a Partnership Deed dated November 30, 2007.
Upon the conversion of M/s Supriya Chemicals' the Partnership Firm into a Public Limited Company, the Company got incorporated as Supriya Lifescience Limited' vide certified on March 26, 2008 by the Registrar of Companies, Mumbai. The Company commenced operations in April, 2008.
It is engaged in manufacturing and export of active pharmaceutical ingredients (APIs).
The company is one of the key Indian manufacturers and suppliers of active pharmaceuticals ingredients,with a focus on research and development.

About Trident Lifeline Ltd

Trident Lifeline Limited was originally incorporated as Private Limited Company as 'Trident Lifeline Private Limited' on January 09, 2014.
Subsequently, Company converted into a Public Limited and the name of Company was changed to 'Trident Lifeline Limited' on June 10, 2022.
The Company is engaged in business of marketing ethical pharmaceutical products in domestic as well as international market.
It is also engaged in distribution of pharmaceutical products through third party distribution network. Apart from these, the Company offer wide range of pharmaceutical formulations and products manufactured on contract manufacturing under loan license.
It operate in India as well as African, Latin American and East Indian Countries.

FAQs for the comparison of Supriya Lifescience Ltd and Trident Lifeline Ltd

Which company has a larger market capitalization, Supriya Lifescience Ltd or Trident Lifeline Ltd?

Market cap of Supriya Lifescience Ltd is 5,589 Cr while Market cap of Trident Lifeline Ltd is 298 Cr

What are the key factors driving the stock performance of Supriya Lifescience Ltd and Trident Lifeline Ltd?

The stock performance of Supriya Lifescience Ltd and Trident Lifeline Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Supriya Lifescience Ltd and Trident Lifeline Ltd?

As of May 4, 2026, the Supriya Lifescience Ltd stock price is INR ₹694.5. On the other hand, Trident Lifeline Ltd stock price is INR ₹250.05.

How do dividend payouts of Supriya Lifescience Ltd and Trident Lifeline Ltd compare?

To compare the dividend payouts of Supriya Lifescience Ltd and Trident Lifeline Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.